This collaboration supports the advancement of the EpiCapture test, which is currently in late-stage development, to regulatory approval and commercialization. This initiative is part of Trinity ...

Trinity Biotech (TRIB) announced a strategic collaboration with a leading bioinformatics company to conduct advanced analysis on clinical trial ...

Therapeutic cancer vaccines have experienced a remarkable resurgence over the past decade, representing a paradigm shift in oncology toward harnessing the immune system's intrinsic ability to combat ...

A team of the University of Barcelona and the Biomedical Research Institute of Barcelona (IRB Barcelona) has designed a new bioinformatics tool to identify the chromosomal alterations that are ...

Complete Genomics, a leading innovator in genomic sequencing technologies, will showcase its expanded portfolio for oncology and infectious disease research at the 2025 Association for Molecular ...

The biomarker, G-protein-coupled receptor 176 (GPR176), may be a driver in the progression of ovarian cancer and potential target for gene therapy, suggested researchers of a new study. Building on ...

The Google search engine has revolutionized knowledge dissemination over the Internet. With more than 3,000 queries per second, each sifting through hundreds of gigabytes of data, Google has blasted a ...

Emma's brain tumour has stopped growing since she gained access to a type of immunotherapy identified by molecular testing.

Interpace Diagnostics Group Inc. ( ($IDXG) ) has released its Q3 earnings. Here is a breakdown of the information Interpace Diagnostics Group Inc.